Other Issues:
previous
|
next
|
latest
|
archive
Volume 7(Suppl 5); 2005
Introduction
Optimizing the Role of Hormonal Therapy in the Management of Prostate Cancer
Herbert Lepor
Rev Urol.
2005;
7
(Suppl 5)
: S1–S2.
PMCID:
PMC1477617
|
Full Text
|
PDF–11K
|
Hormonal Therapy and Prostate Cancer
Comparison of Single-Agent Androgen Suppression for Advanced Prostate Cancer
Herbert Lepor
Rev Urol.
2005;
7
(Suppl 5)
: S3–S12.
PMCID:
PMC1477619
|
Abstract
|
Full Text
|
PDF–53K
|
Maximum Androgen Blockade: A Clinical Update
Gerald W Chodak
Rev Urol.
2005;
7
(Suppl 5)
: S13–S17.
PMCID:
PMC1477614
|
Abstract
|
Full Text
|
PDF–41K
|
Addressing the Needs of the High-Risk Prostate Cancer Patient
Leonard G Gomella
Rev Urol.
2005;
7
(Suppl 5)
: S18–S28.
PMCID:
PMC1477615
|
Abstract
|
Full Text
|
PDF–70K
|
The Effective Management of Biochemical Recurrence in Patients with Prostate Cancer
David G McLeod
Rev Urol.
2005;
7
(Suppl 5)
: S29–S36.
PMCID:
PMC1477616
|
Abstract
|
Full Text
|
PDF–887K
|
Adverse Events Associated with Hormonal Therapy for Prostate Cancer
Ravi J Kumar, Al Barqawi, and E. David Crawford
Rev Urol.
2005;
7
(Suppl 5)
: S37–S43.
PMCID:
PMC1477613
|
Abstract
|
Full Text
|
PDF–49K
|
Reimbursement Issues with Hormonal Therapies for Prostate Cancer
M. Ray Painter
Rev Urol.
2005;
7
(Suppl 5)
: S44–S47.
PMCID:
PMC1477618
|
Abstract
|
Full Text
|
PDF–29K
|
Other Issues:
previous
|
next
|
latest
|
archive
